INTRODUCTION
============

Cystic echinococcosis (CE), a chronic parasitic zoonosis, is caused by infection with the larval stage of the cestode *Echinococcus granulosus* (*E. granulosus*), resulting in the development of cysts in humans and domestic animals ([@b4-ajas-25-12-1660-2]). The disease presents high risk to human health in areas of poor sanitary and hygiene conditions. Also, CE causes considerable health problems in animals and economical disadvantages due to production loss, as animals infected with this disease often suffer reductions in live weight gain, milk yield, fertility rates and the value of wool or other products ([@b24-ajas-25-12-1660-2]). Hence, CE control is a vital part of health and production management in domestic animals, especially in sheep, because sheep appear to be highly susceptible to infection ([@b16-ajas-25-12-1660-2]). A variety of methods have been applied to minimize the impact of CE, including grazing management, medical control and vaccination. These methods have the advantage of being easy to plan and record, and historically, have been effective ([@b26-ajas-25-12-1660-2]). However, using drugs frequently can cause problems like parasites developing resistance to drugs and public concern about chemical residues in animal products and the environment ([@b19-ajas-25-12-1660-2]). On the other hand, vaccination is expensive for pastoral areas in northwestern China. A new approach that relies on sustainable methods, therefore, should be employed.

Major histocompatibility complex (MHC), an organized cluster of tightly-linked genes, encodes the molecules that bind processed peptide antigens including parasite-derived peptides and presents them to T-lymphocytes, thereby triggering antigen-specific immune responses ([@b17-ajas-25-12-1660-2]). In sheep, the MHC gene family includes two major subfamilies: class I and class II genes ([@b11-ajas-25-12-1660-2]). Among sheep MHC class II genes, the expressed DRB1 and DQB1 loci have been found to be highly polymorphic ([@b25-ajas-25-12-1660-2]; [@b13-ajas-25-12-1660-2]; [@b23-ajas-25-12-1660-2]). In particular, a high polymorphism level is present in exon 2, which encodes the antigen-binding site ([@b18-ajas-25-12-1660-2]; [@b12-ajas-25-12-1660-2], [@b13-ajas-25-12-1660-2]). Variation in these genes may impact immune responses to pathogens, which may lead to variation in disease resistance. In the recent years, a large number of meaningful association studies have been carried out in sheep, especially on resistance to: i) nematodiasis such as gastronintestinal nematodiasis ([@b3-ajas-25-12-1660-2]; [@b20-ajas-25-12-1660-2]; [@b22-ajas-25-12-1660-2]); ii) bacterial diseases like bacterial footrot ([@b7-ajas-25-12-1660-2]); and iii) viral diseases such as BLV-induced ovine lymphoma, Maedi Visna and pulmonary adenocarcinoma viral diseases ([@b1-ajas-25-12-1660-2]; [@b13-ajas-25-12-1660-2]; [@b14-ajas-25-12-1660-2]). However, to our knowledge, no study on the MHC-DQB1 gene and CE association in sheep has been published, although we previously found that different MHC-DRB1 genotypes were associated with different susceptibilities of CE in Kazakh sheep, a native Chinese sheep breed ([@b15-ajas-25-12-1660-2]).

Chinese Merino sheep, well known for their characteristics of good wool and meat production, is beneficial to local sheep industry; however, they are relatively more susceptible to CE ([@b9-ajas-25-12-1660-2]). The prevalence of CE in Chinese Merino sheep causes considerable economic problems due to the loss of production. These losses are of especial significance in Xinjiang (northwestern China) a region of low economic output where sheep production is of particular importance. Hence, it is of great urgency to treat and manage CE in Chinese Merino sheep. An alternative method is to selectively breed sheep for disease resistance using genetic markers.

Our previous study has shown that different MHC-DQB1 mRNA expression levels were detected between different outcomes of CE infections in Chinese Merino sheep ([@b9-ajas-25-12-1660-2]). So, in this study, we were curious to see whether variation in MHC-DQB1 was associated with susceptibility or resistance to CE in Chinese Merino sheep. If so, it would lay a theoretical foundation for future breeding disease resistance sheep.

MATERIALS AND METHODS
=====================

Animals
-------

All sheep included in this study were 1-yr-old unrelated female Chinese Merino sheep from the farm located in Mission 165, agricultural division 9, Xinjiang Production and Construction Corps. According to the recommendation of WHO-IWG, ultrasonography and serological methods were combined to distinguish between CE sheep and healthy individuals in the flock. If the sheep were negative for antibodies to hydatid cyst fluid (HCF) antigen, assayed by a commercial ovine hydatidosis ELISA kit (Shenzhen Combined Biotech Co.), and no hydatid cysts present in internal organs as detected by ultrasonography (50 S Tringa VetôPie Medical, Netherland), they were designated as the healthy cohort. If the sheep were positive for antibodies to HCF antigen, and had cysts in the internal organs as determined by ultrasonography, and further had protoscolices visualized by microscopy, they were designated as the CE cohort. Of all the selected sheep, there were 101 CE sheep and 103 healthy controls.

DNA extraction
--------------

Genomic DNA was isolated from the whole blood using phenol-chlorophorm extraction, and stored at −20°C until analysis (Major reagents were from Promega Company and Shanghai Sangon Biological Engineering Technology And Service Co, Ltd.).

PCR amplification for MHC-DQB1 gene
-----------------------------------

The second exon of DQB1 was amplified with primers FW: 5′-CCC CGC AGA GGA TTT CGT G-3′ and REV: 5′-ACC TCG CCG CTG CCA GGT-3′ ([@b2-ajas-25-12-1660-2]), sequence logging number Z28523. Genomic DNA (150 ng) was amplified in a total volume of 50 μl, including 1.5 mM MgCl~2~, 100 μM dNTPs, 0.2 mM of each primer, and 2 U of Taq polymerase. Reactions were performed in a thermocycler under the following conditions: one cycle of incubation for 5 min at 94°C, followed by 33 cycles of 94°C for 30 s, 67°C for 30 s, and 72°C for 45 s, with final extension at 72°C for 10 min.

Polymorphism detection by RFLP
------------------------------

RFLP protocol was carried out to examine the nucleotide sequence variability at the second exon of DQB1 locus, according to the method described by [@b12-ajas-25-12-1660-2], with modifications. Aliquots (10 μl) of DQB1 PCR product were digested with 5 U of *Mro*xI, *Sca*I, *Sac*II, *Nci*I, *Taq*I, *Mva*I, and *Hae*III, respectively. The condition of restriction enzymes digestions and fragment visualizations can be seen in [Table 1](#t1-ajas-25-12-1660-2){ref-type="table"}. Gene typing method and genotype nomenclature is in accordance with [@b12-ajas-25-12-1660-2] and Li et al. ([Table 2](#t2-ajas-25-12-1660-2){ref-type="table"}).

Statistical analysis
--------------------

Data were analyzed with the Statistical Package for Social Science version 13.0 for Windows. In order to assess the statistical significance of association of different genotype and genotype frequencies with CE susceptibility or resistance, the *x*^2^ test with Yates' correction for continuity was applied. The degree of association was calculated using odds ratio (OR; [@b6-ajas-25-12-1660-2]). Significance was accepted at 0.05 for all of the tests.

RESULTS
=======

PCR amplification of MHC-DQB1 exon 2 genes
------------------------------------------

Ovar-DQB1 exon 2 was amplified by PCR with primers FW and REV, and one specific band of 280 bp was observed on 2% agarose.

MHC- DQB1 RFLP typing
---------------------

The following numbers of alleles and RFLP patterns detected with each restriction enzyme were observed in MHC-DQB1: *Mro*xI, 2, 3; *Sca*I, 2, 3; *Sac*II, 4, 7; *Nci*I, 2, 3; *Taq*I, 3, 4; *Mva*I, 6, 16 and *Hae*III, 3, 6 ([Tables 3](#t3-ajas-25-12-1660-2){ref-type="table"} and [4](#t4-ajas-25-12-1660-2){ref-type="table"}). A total of 22 alleles and 42 RFLP patterns were identified in DQB1 exon 2 in Chinese Merino sheep. Allele frequencies were also calculated at each restriction enzyme site ([Table 4](#t4-ajas-25-12-1660-2){ref-type="table"}). In addition, the Hardy-Weinberg test was performed to detect whether individual variants were in equilibrium at the locus detected. The Chi-Square values of the seven restriction enzymes *Mro*xI, *Sca*I, *Sac*II, *Nci*I, *Taq*I, *Mva*I, and *Hae*III were 5.9568 (p\>0.05), 80.1527(p\<0.01), 24.3947 (p\<0.01), 134.3837 (p\<0.01), 2.3968 (p\>0.05), 359.7055 (p\<0.01) and 78.1706 (p\<0.01), respectively. The results suggested that the sites of *Mro*xI and *Taq*I were within Hardy-Weinberg balance, while the sites of the others were not within Hardy-Weinberg balance.

Analysis of association between MHC-DQB1 genotypes and CE
---------------------------------------------------------

We compared the distribution of MHC-DQB1 genotypes, both frequency and percentage, and found that higher frequencies were statistically significant in the case of DQB1-*Taq*Iaa and DQB1-*Hae*IIInn (p = 0.000, 0.000, respectively) in the healthy group (OR = 0.286, 0.303; 95% CI = 0.150--0.544, 0.167--0.550, respectively) than that in CE group, which might be associated with resistance to CE ([Table 3](#t3-ajas-25-12-1660-2){ref-type="table"}).

In contrast, we found that the frequencies of DQB1-*Taq*Iab and DQB1-*Hae*IIImn genotypes were significantly higher in the CE group (36.9% and 32.0%, respectively) than those in the healthy group (16.5% and 11.15%, respectively) (p = 0.001, 0.001 and OR = 2.963, 3.629, respectively), which might be associated with susceptibility to CE ([Table 3](#t3-ajas-25-12-1660-2){ref-type="table"}).

Results of agarose gel electrophoresis for the two enzymes (*Taq*I and *Hae*III), are illustrated in [Figure 1](#f1-ajas-25-12-1660-2){ref-type="fig"} and [2](#f2-ajas-25-12-1660-2){ref-type="fig"}.

DISCUSSION
==========

It has been demonstrated that there are two main approaches, using polymorphisms, in the identification of genes involved in polygenic diseases. The first is examining inheritance patterns for genetic polymorphisms in family studies and the second is population case-control studies which compare genotype frequencies for candidate genes in individuals with the disease and healthy controls ([@b5-ajas-25-12-1660-2]). An MHC gene or region is considered to be associated with a particular disease if one or more alleles or genotypes are found to be more or less common in diseased individuals compared to control groups ([@b21-ajas-25-12-1660-2]). In this study, we investigated MHC-DQB1 loci and CE association in Chinese Merino sheep by comparing the frequency of genotypes in CE sheep and those in healthy individuals. This approach is feasible and has already been applied in MHC-DRB1 loci and CE association studies in Kazak sheep ([@b15-ajas-25-12-1660-2]), although the MHC loci detected is different.

Different methods have been employed for typing the MHC-DQB1 gene in various sheep breeds and have revealed extensive polymorphism at these loci. [@b8-ajas-25-12-1660-2] used SSCP methods to detect MHC-DQB1 in Scottish Black-face sheep, who found 16 new alleles. In the present study, we applied the PCR-RFLP method to identify DQB1 exon 2 polymorphisms in Chinese Merino sheep. A total of 22 alleles and 42 RFLP patterns were identified. The polymorphisms existed at the positions of the 226th, 246th, 231st, 217th, 213th, 198th, 192nd, 174th, 161st, 140th, 96th and 34th base pairs. The extensive diversity at many MHC loci provides a valuable source of genetic markers for examining the complex relationships between host genotype and disease resistance or susceptibility. For example, [@b20-ajas-25-12-1660-2] suggested that the MHC gene plays an important role in the enhanced resistance of Suffolk sheep to nematode infection. In this study, the high polymorphism of MHC-DQB1 gene suggested that Chinese Merino sheep are excellent material for studying the relationship between MHC and disease resistance or susceptibility.

In the present study, we found that genotypes of DQB1-*Taq*Iaa and DQB1-*Hae*IIInn showed a negative statistically significant association with the occurrence of CE in Chinese Merino sheep, indicating that these genotypes might be suitable genetic resistant markers against CE. On the other hand, we also found that genotypes of DQB1-*Taq*Iab and DQB1-*Hae*IIImn showed a positively significant association, indicating that they might be genetic markers of susceptibility to CE. Our previous study ([@b15-ajas-25-12-1660-2]) analyzed the relationship between MHC-DRB1 gene polymorphism and CE in Kazakh sheep by PCR-RFLP method, and found that the genotype of *Mva*Ibc, *Hin*1Iab, *Hae*IIIdd, *Hae*IIIde, *Hae*IIIdf and *Sac*IIab appeared to confer protection against CE in Kazakh sheep, while genotypes of *Mva*Ibb, *Sac*IIaa, *Hin*1Ibb and *Hae*IIIef were found to confer susceptiblility to the disease. Comparing the present results with the above finding, however, there were also variation existing in the genotypes in terms of genetic markers, which may be related to the different loci of MHC genes, different sheep breed, or particularly due to genetic variation within the *Echinococcus* sp.

In conclusion, in the current circumstance there is a lack of information about the relationship between MHC and CE, this study reports within-breed genetic variation to parasite susceptibility/resistance to CE disease in Chinese Merino sheep, the results emphasized that MHC were significant factors for the development of CE or protection against CE in Chinese Merino sheep, which would pave the way for breeding disease resistance sheep in future. However, regarding that MHC-disease association is influenced by multiple factors, such as parasite disease biology, genetic background of animal, sample size and especially ovar-MHC typing method, further work (e.g., sample amplification and experimental infection with *E. granulosus*) is required to carry out, which will provide more meaningful association.
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![Electrophoretic patterns of the second exon of MHC-*DQB1* digested with *Hae*III in Chinese Merino sheep. lane1, 9: *Hae*III mm; lane 2, 3, 4, 5: *Hae*III nn; lane 7, 8: *Hae*III mn; lane 6: free; M: puc19 DNA marker.](ajas-25-12-1660-2f1){#f1-ajas-25-12-1660-2}

![Electrophoretic patterns of the second exon of MHC-*DQB* 1digested with *Taq*I in Chinese Merino sheep. M: puc19 DNA marker; lane 1, 2, 3, 4, 5, 6, 8, 10, 12, 13, 14, 15: *Taq*I aa; lane 7: *Taq*I ac;lane 9, 11, 16: *Taq*I ab.](ajas-25-12-1660-2f2){#f2-ajas-25-12-1660-2}

###### 

Conditions of restriction enzymes and examination of digested PCR product of MHC-*DQB*1 exon 2

  Restriction enzymes   Digest-temperature (°C)   Digest-time (h)   Concentration of agarose gel (%)   Recognition site
  --------------------- ------------------------- ----------------- ---------------------------------- --------------------------------------------------------------
  *Taq*I                65                        5                 2.5                                T[\*](#tfn1-ajas-25-12-1660-2){ref-type="table-fn"}CGA
  *Mva*I                37                        5                 2.5                                CC[\*](#tfn1-ajas-25-12-1660-2){ref-type="table-fn"}(A/T)GG
  *Hae*III              37                        4                 2.5                                GG[\*](#tfn1-ajas-25-12-1660-2){ref-type="table-fn"}CC
  *Mrox*I               37                        4                 2.5                                GAANN[\*](#tfn1-ajas-25-12-1660-2){ref-type="table-fn"}NNTTC
  *Sca*I                38                        6                 3.0                                AGT[\*](#tfn1-ajas-25-12-1660-2){ref-type="table-fn"}ACT
  *Sac*II               37                        4                 2.5                                CCGC[\*](#tfn1-ajas-25-12-1660-2){ref-type="table-fn"}GG
  *Nci*I                37                        5                 2.5                                GG(G/C)[\*](#tfn1-ajas-25-12-1660-2){ref-type="table-fn"}CC

Represents recognition site;/Represents recognition of A or T.

###### 

The genotypes of PCR-RFLP in ovar-DQB1 exon 2

  Restriction enzymes                                                               The genotypes of each restriction enzyme                                                     
  ------------------------------- ------------------------------------------------- ------------------------------------------ ------------------------------------------------- -------------------------------------
  *Taq*I                          aa(165 bp/115 bp)                                 bb(231 bp/49 bp)                           ab(231 bp/165 bp/115 bp/49 bp)                    ac(280 bp/165 bp/115 bp)
  *Mrox*I                         aa(280 bp)                                        bb(192 bp/88 bp)                           ab(280 bp/192 bp/88 bp)                           
  *Sca*I                          aa(280 bp)                                        bb(174 bp/106 bp)                          ab(280 bp/174 bp/106 bp)                          
  *Nci*I                          gg(280 bp)                                        xx(140 bp)                                 xg(280 bp/140 bp)                                 
  *Sac*II                         aa(280 bp)                                        bb(140 bp/140 bp)                          cc(217 bp/63 bp)                                  ab(280/140 bp/140 bp)
  ac(280 bp/217 bp/63 bp)         bd(140 bp/77 bp/63 bp)                            ad(280 bp/140 bp/77 bp/63 bp)                                                                
  *Hae*III                        aa(213 bp/67 bp)                                  bb(127 bp/67 bp/52 bp/34 bp)               cc(179 bp/67 bp/34 bp)                            bc(179 bp/127 bp/67 bp/52 bp/34 bp)
  ab(213 bp/179 bp/67 bp/34 bp)   ac(213 bp/179 bp/67 bp/34 bp)                                                                                                                  
  *Mva*I                          aa(198 bp/82 bp)                                  bb(266 bp/14 bp)                           cc(198 bp/68 bp/14 bp)                            dd(280 bp)
  yy(150 bp/96 bp/20 bp/14 bp)    zz(102 bp/96 bp/48 bp/20 bp/14 bp)                ad(280 bp/198 bp/82 bp)                    az(198 bp/102 bp/96 bp/82 bp/48 bp/20 bp/14 bp)   
  bc(266 bp/198 bp/68 bp/14 bp)   bd(280 bp/266 bp/14 bp)                           by(266 bp/150 bp/96 bp/20 bp/14 bp)        bz(266 bp/102 bp/96 bp/48 bp/20 bp/14 bp)         
  cd(280 bp/198 bp/68 bp/14 bp)   cz(198 bp/102 bp/96 bp/68 bp/48 bp/20 bp/14 bp)   dy(280 bp/150 bp/96 bp/20 bp/14 bp)        dz(280 bp/102 bp/96 bp/48 bp/20 bp/14 bp)         

###### 

Distribution of MHC-DQB1 genotypes in CE sheep and healthy controls

  Genotype n = 42     CE sheep n = 101   Healthy sheep n = 103   *x*^2^ with correction   p value    OR      95% CI
  ------------------- ------------------ ----------------------- ------------------------ ---------- ------- --------------
  *Mrox*I-RFLP (3)                                                                                           
   *Mrox*I aa         28(43.8%)          31(44.9%)               0                        1, NS              
   *Mrox*I ab         25(39.1%)          24(34.8%)               0.11                     0.74, NS           
   *MroxI* bb         11(17.2%)          14(20.3%)               0.055                    0.814,NS           
  *Sca*I-RFLP (3)                                                                                            
   *Sca*I aa          14(19.7%)          10(11.8%)               1.319                    0.251,NS           
   *Sca*I ab          57(80.3%)          74(87.1%)               0.865                    0.352,NS           
   *Sca*I bb          0(0%)              1(1.2%)                 0                        1, NS              
  *Nci*I-RFLP (3)                                                                                            
   *Nci*I xx          66(70.2%)          60(70.6%)               0                        1, NS              
   *Nci*I gg          20(21.3%)          16(18.8%)               0.049                    0.824,NS           
   *Nci*I xg          8 (8.5%)           9(10.6%)                0.07                     0.792,NS           
  *Sac*II-RFLP (7)                                                                                           
   *Sac*II aa         37(59.7%)          25(44.6%)               2.098                    0.147,NS           
   *Sac*II bb         0 (0%)             3(5.4%)                 1.589                    0.207,NS           
   *Sac*II cc         7 (11.3%)          5(8.9%)                 0.014                    0.905,NS           
   *Sac*II ab         4 (6.5%)           10(17.9%)               2.651                    0.103,NS           
   *Sac*II ac         8 (12.9%)          12(21.4%)               0.974                    0.324,NS           
   *Sac*II ad         5 (8.1%)           1(1.8%)                 1.279                    0.258,NS           
   *Sac*II bd         1 (1.6%)           0(0%)                   0                        1, NS              
  *Taq*I-RFLP (4)                                                                                            
   *Taq*I aa\*        58(57.4%)          85(82.5%)               14.152                   0, HS      0.286   0.150--0.544
   *Taq*I bb          1(1%)              1(1%)                   0                        1, NS              
   *Taq*I ab\*\*      41(36.9%)          17(16.5%)               10.278                   0.001,HS   2.963   1.551--5.661
   *Taq*I ac          1(1.6%)            0(0%)                   0                        0.992,NS           
  *Mva*I-RFLP (16)                                                                                           
   *Mva*I aa          3(3.6%)            7(7.4%)                 0.576                    0.448,NS           
   *Mva*I bb          1(1.2%)            0(0%)                   0.005                    0.946,NS           
   *Mva*I cc          18(21.7%)          13(13.7%)               1.455                    0.228,NS           
   *Mva*I dd          4(4.8%)            12(12.6%)               2.419                    0.12, NS           
   *Mva*I zz          16(19.3%)          22(23.2%)               0.2                      0.655,NS           
   *Mva*I yy          14(16.9%)          15(15.8%)               0                        1, NS              
   *Mva*I ad          0(0%)              1(1.1%)                 0                        1, NS              
   *Mva*I az          1(1.2%)            3(3.2%)                 0.137                    0.711,NS           
   *Mva*I bc          1(1.2%)            0(0%)                   0.005                    0.946,NS           
   *Mva*I bd          1(1.2%)            0(0%)                   0.005                    0.946,NS           
   *Mva*I bz          1(1.2%)            0(0%)                   0.005                    0.946,NS           
   *Mva*I by          0(0%)              2(2.1%)                 0.38                     0.537,NS           
   *Mva*I cd          6(7.2%)            3(3.2%)                 0.799                    0.371,NS           
   *Mva*I cz          14(16.9%)          7(7.4%)                 2.983                    0.084,NS           
   *Mva*I dz          2(2.4%)            9(9.5%)                 2.692                    0.101,NS           
  *Hae*III-RFLP (6)                                                                                          
   *Hae*III aa        0(0%)              3(3.1%)                 1.376                    0.241,NS           
   *Hae*IIImm         32(33.0%)          24(25.0%)               1.133                    0.287,NS           
   *Hae*III nn\*      28(28.9%)          55(57.3%)               14.767                   0, HS      0.303   0.167--0.550
   *Hae*III am        3(3.1%)            1(1.0%)                 0.245                    0.621,NS           
   *Hae*III an        3(3.1%)            2(2.1%)                 0                        1, NS              
   *Hae*III mn\*\*    31(32%)            11(11.5%)               10.736                   0.001,HS   3.629   1.699--7.755

OR = Odds ratio, CI = Confidence interval, HS = Highly significant, S = Significant, NS = Not significant.

"\*" Means that these genotypes are associated with resistance to CE, while "\*\*" means that these genotypes are associated with susceptibility to CE.

###### 

Frequencies of MHC-DQB1 alleles in CE sheep and healthy controls

  Alleles         CE sheep   Healthy sheep         
  --------------- ---------- --------------- ----- --------
  *Mrox*I- (2)                                     
   *Mrox*I a      81         63.28%          86    62.32%
   *Mrox*I b      47         36.72%          52    37.68%
  *Sca*I- (2)                                      
   *Sca*I a       85         59.85%          94    55.29%
   *Sca*I b       57         40.15%          76    44.71%
  *Nci*I- (2)                                      
   *Nci*I x       140        74.46%          129   75.88%
   *Nci*I g       48         25.54%          41    24.12%
  *Sac*II- (4)                                     
   *Sac*II a      91         73.39%          73    65.18%
   *Sac*II b      5          4.03%           16    14.29%
   *Sac*II c      22         17.74%          22    19.64%
   *Sac*II d      6          4.84%           1     0.86%
  *Taq*I- (3)                                      
   *Taq*I a       187        90.78%          158   78.22%
   *Taq*I b       19         9.22%           43    21.29%
   *Taq*I c       0          0%              1     0.51%
  *Mva*I- (6)                                      
   *Mva*I a       7          4.22%           18    9.47%
   *Mva*I b       5          3.01%           2     1.05%
   *Mva*I c       57         34.34%          36    18.95%
   *Mva*I d       18         10.84%          38    20%
   *Mva*I y       29         17.47%          33    17.34%
   *Mva*I z       50         30.12%          63    33.16%
  *Hae*III- (3)                                    
   *Hae*III a     6          3.08%           9     4.69%
   *Hae*III m     98         50.52%          60    31.25%
   *Hae*III n     90         46.4%           123   64.06%
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